Benjamin Cohen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Benjamin Cohen has a total of 122 co-authors. Here are the top co-authors by number of shared publications:
- Gregory L. Beutner
Chemical Process Development, Bristol Myers Squibb, 1 Squibb Drive, New Brunswick, New Jersey 08903, United States
7 shared publications - Albert J. DelMonte
Chemical Process Development, Bristol Myers Squibb, One Squibb Drive, New Brunswick, New Jersey 08903, United States
3 shared publications Christopher Wilbert
Bristol-Myers Squibb Company One Squibb Drive
3 shared publications- Dan Lehnherr
Process Research & Development, Merck & Co., Inc., Rahway, USA
3 shared publications - Lin Deng
Small Molecule Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States
3 shared publications Michael O. Frederick
Synthetic Molecule Design and Development
3 shared publications
Latest Publications
- 5 October 2026
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 30 (10) , 2767-2782
Development of a Stereoselective Route for Kilogram-Scale Synthesis of STING Agonist BMS-986301
Following the discovery of a chiral P(V) reagent to enable diastereoselective synthesis of stereogenic thiophosphoramidates, we have developed a scalable synthesis to deliver kilogram quantities of the STING agonist BMS-986301. The route not only reduced the number of steps compared to the enabling route but also avoided the use of hazardous reagents. Further development enabled the use of crystallizations to isolate intermediates, effectively eliminating six chromatographic purifications. This resulted in an eightfold improvement in yield and 90% reduction in process mass intensity (PMI). The route was successfully implemented in a pilot-plant campaign to deliver 1.65 kg of BMS-986301 (1) and was therefore deemed suitable as a long-term option for commercial synthesis.
- 5 October 2026
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 30 (10) , 2767-2782
Development of a Stereoselective Route for Kilogram-Scale Synthesis of STING Agonist BMS-986301
Following the discovery of a chiral P(V) reagent to enable diastereoselective synthesis of stereogenic thiophosphoramidates, we have developed a scalable synthesis to deliver kilogram quantities of the STING agonist BMS-986301. The route not only reduced the number of steps compared to the enabling route but also avoided the use of hazardous reagents. Further development enabled the use of crystallizations to isolate intermediates, effectively eliminating six chromatographic purifications. This resulted in an eightfold improvement in yield and 90% reduction in process mass intensity (PMI). The route was successfully implemented in a pilot-plant campaign to deliver 1.65 kg of BMS-986301 (1) and was therefore deemed suitable as a long-term option for commercial synthesis.
- Open Access
- 16 June 2026
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 30 (7) , 1926-1936
Development of Kilogram-Scale Electrochemical Ni-Catalyzed Cross Electrophile Coupling in Flow
Organic electrosynthesis opens novel routes for pharmaceutical production; however, limited knowledge and experience with the scale up of this technique have hindered its industrial implementation. In this work, we report a kilogram-scale flow electrochemical Ni-catalyzed cross-electrophile coupling (XEC) to prepare a key intermediate in the synthesis of the toll-like receptor (TLR) 7/8 inhibitor afimetoran. We successfully demonstrate scalability across 2 orders of magnitude while maintaining reaction performance. We also conduct a continuous 120 h reaction, highlighting compatibility with industrially relevant time scales. Key design aspects of our custom parallel-plate reactor are discussed that enabled kilogram-scale synthesis with a single electrode stack. This report showcases that with proper reaction engineering, electrochemical Ni-catalyzed XEC is a viable alternative to existing Pd-catalyzed cross-coupling methods.
- 16 June 2026
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 30 (7) , 1926-1936
Open AccessDevelopment of Kilogram-Scale Electrochemical Ni-Catalyzed Cross Electrophile Coupling in Flow
Organic electrosynthesis opens novel routes for pharmaceutical production; however, limited knowledge and experience with the scale up of this technique have hindered its industrial implementation. In this work, we report a kilogram-scale flow electrochemical Ni-catalyzed cross-electrophile coupling (XEC) to prepare a key intermediate in the synthesis of the toll-like receptor (TLR) 7/8 inhibitor afimetoran. We successfully demonstrate scalability across 2 orders of magnitude while maintaining reaction performance. We also conduct a continuous 120 h reaction, highlighting compatibility with industrially relevant time scales. Key design aspects of our custom parallel-plate reactor are discussed that enabled kilogram-scale synthesis with a single electrode stack. This report showcases that with proper reaction engineering, electrochemical Ni-catalyzed XEC is a viable alternative to existing Pd-catalyzed cross-coupling methods.
- Open Access
- 11 February 2025
- Published by American Chemical Society (ACS) in ACS Central Science
- Vol. 11 (4) , 528-538
Scaling Organic Electrosynthesis: The Crucial Interplay between Mechanism and Mass Transport
Organic electrosynthesis opens new avenues of reactivity and promises more sustainable practices in the preparation of fine chemicals and pharmaceuticals. The full value of this approach will be realized by taking these processes to the production scale; however, achieving this goal will require a better understanding of the influence of mass transport on reaction behavior and the interactions between reactive species and electrodes inherent to organic electrosynthesis. The limited options for cell geometries used on small scale limit elucidation of these features. Here, we show how advanced cell geometries allow us to control the interplay between reaction mechanism and mass transport, leading to improved performance of three modern organic electrosynthetic reactions. Each reaction shows a unique relationship with mass transport, highlighting the importance of understanding this relationship further to maximize the utility of organic electrosynthesis at scale.
- 11 February 2025
- Published by American Chemical Society (ACS) in ACS Central Science
- Vol. 11 (4) , 528-538
Open AccessScaling Organic Electrosynthesis: The Crucial Interplay between Mechanism and Mass Transport
Organic electrosynthesis opens new avenues of reactivity and promises more sustainable practices in the preparation of fine chemicals and pharmaceuticals. The full value of this approach will be realized by taking these processes to the production scale; however, achieving this goal will require a better understanding of the influence of mass transport on reaction behavior and the interactions between reactive species and electrodes inherent to organic electrosynthesis. The limited options for cell geometries used on small scale limit elucidation of these features. Here, we show how advanced cell geometries allow us to control the interplay between reaction mechanism and mass transport, leading to improved performance of three modern organic electrosynthetic reactions. Each reaction shows a unique relationship with mass transport, highlighting the importance of understanding this relationship further to maximize the utility of organic electrosynthesis at scale.
- 27 January 2025
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 29 (2) , 322-332
Adoption of Electrochemistry within the Pharmaceutical Industry: Insights from an Industry-Wide Survey
- 27 January 2025
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 29 (2) , 322-332
Adoption of Electrochemistry within the Pharmaceutical Industry: Insights from an Industry-Wide Survey
- 16 December 2024
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 29 (1) , 114-125
Use of Population Balance Modelling to Derisk Scale-Up of an Integrated Crystallization–Wet Milling Process
- 16 December 2024
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 29 (1) , 114-125
Use of Population Balance Modelling to Derisk Scale-Up of an Integrated Crystallization–Wet Milling Process
- 29 September 2022
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 26 (10) , 2847-2854
Implementation of MSMPR Crystallization to Avoid Liquid–Liquid Phase Separation
- 29 September 2022
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 26 (10) , 2847-2854
Implementation of MSMPR Crystallization to Avoid Liquid–Liquid Phase Separation
- Open Access
- 11 January 2020
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 24 (2) , 172-182
Safe Scale-up of an Oxygen-Releasing Cleavage of Evans Oxazolidinone with Hydrogen Peroxide
In the pharmaceutical industry, H2O2-mediated oxidation reactions are commonly used in chemical syntheses but they can also introduce unexpected safety hazards. Our labs recently reported on the discovery of oxygen evolution during the LiOH/H2O2-mediated cleavage of Evans oxazolidinone. Faced with this previously unexpected hazard, the authors, herein, report on the development and demonstration of a methodology for the safe scale-up of this O2-releasing reaction. It was found that O2 in the headspace could be controlled by a combination of N2 sweeping and modulation of the LiOH addition rate. A design of experiment study was used to probe the multivariate parameter space in order to minimize formation of the unstable peracid intermediate, thus avoiding accumulation and subsequent risk of rapid and uncontrolled O2 release. To support scale-up, the well-mixed vapor headspace assumption was tested using computational fluid dynamics, and it was found that N2 sparging is effective at reducing heterogeneity in the headspace. Condenser conditions were evaluated to balance recovery of solvent—because of the high N2 sweep—and avoid the risk of condenser freezing—because of the presence of water in the condensate. An additional fail safe was developed, using a pH buffer to rapidly halt the base-catalyzed reaction in the case of an unexpectedly high headspace O2 concentration. The final process was validated and executed at up to 215 kg scale.
- 11 January 2020
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 24 (2) , 172-182
Open AccessSafe Scale-up of an Oxygen-Releasing Cleavage of Evans Oxazolidinone with Hydrogen Peroxide
In the pharmaceutical industry, H2O2-mediated oxidation reactions are commonly used in chemical syntheses but they can also introduce unexpected safety hazards. Our labs recently reported on the discovery of oxygen evolution during the LiOH/H2O2-mediated cleavage of Evans oxazolidinone. Faced with this previously unexpected hazard, the authors, herein, report on the development and demonstration of a methodology for the safe scale-up of this O2-releasing reaction. It was found that O2 in the headspace could be controlled by a combination of N2 sweeping and modulation of the LiOH addition rate. A design of experiment study was used to probe the multivariate parameter space in order to minimize formation of the unstable peracid intermediate, thus avoiding accumulation and subsequent risk of rapid and uncontrolled O2 release. To support scale-up, the well-mixed vapor headspace assumption was tested using computational fluid dynamics, and it was found that N2 sparging is effective at reducing heterogeneity in the headspace. Condenser conditions were evaluated to balance recovery of solvent—because of the high N2 sweep—and avoid the risk of condenser freezing—because of the presence of water in the condensate. An additional fail safe was developed, using a pH buffer to rapidly halt the base-catalyzed reaction in the case of an unexpectedly high headspace O2 concentration. The final process was validated and executed at up to 215 kg scale.
- 18 October 2019
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 23 (11) , 2482-2498
Rapid Development of a Commercial Process for Linrodostat, an Indoleamine 2,3-Dioxygenase (IDO) Inhibitor
- 18 October 2019
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 23 (11) , 2482-2498
Rapid Development of a Commercial Process for Linrodostat, an Indoleamine 2,3-Dioxygenase (IDO) Inhibitor